Announcements Trials
Browse Landscape

Phase

Phase 2 116Phase 3 79Phase 1/2 40Phase 1 37Phase 2/3 12Phase NA 10Phase EARLY_PHASE1 4Phase 4 2

Status

Completed 9Unknown 8Terminated 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Stomach Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1Breast Neoplasm Female 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Paclitaxel × Clear all
NCT05183126 2026-03-06

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

University of Michigan Rogel Cancer Center

Phase 4 Recruiting
22 enrolled
BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT03096418 2026-01-16

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

University of Wisconsin, Madison

Phase 4 Recruiting
50 enrolled 12 charts
Breast

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡